Pharma major Dr Reddy’s Laboratories (DRL) recently completed 10 years of its listing on the New York Stock Exchange. Company vice chairman and CEO GV Prasad, who rang the opening bell on Friday, said that becoming an NYSE-listed company 10 years ago had helped the company compete more effectively in the US, its largest market outside of India in terms of revenues. DRL is the first Indian company to celebrate its 10-year anniversary at the NYSE.
Top Section
Explore Business Standard